(Q45340890)

13 December 2017

title

PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice (English)

1 reference

13 December 2017

1 reference

ChEBI release 2020-05-28

1 reference

Kunal Kapoor

1

1 reference

13 December 2017

Esha Singla

series ordinal

2

1 reference

13 December 2017

Bijayani Sahu

series ordinal

3

1 reference

13 December 2017

Amarjit S Naura

series ordinal

4

1 reference

13 December 2017

publication date

18 November 2014

1 reference

Molecular and Cellular Biochemistry

13 December 2017

published in

1 reference

13 December 2017

volume

400

1 reference

13 December 2017

issue

1-2

1 reference

13 December 2017

page(s)

153-162

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-014-2271-4

13 December 2017

exact match

0 references

cites work

The acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Incidence and outcomes of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Quality of life after acute respiratory distress syndrome: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Pathophysiology of acute lung injury and the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Acute lung injury and the acute respiratory distress syndrome: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Animal models of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Differential effects of kidney-lung cross-talk during acute kidney injury and bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Advances in critical care for the nephrologist: acute lung injury/ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

21 January 2018

PARP goes transcription

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Inhibition of poly(adenosine diphosphate-ribose) polymerase attenuates ventilator-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Targeted therapy for cancer using PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates lung-kidney crosstalk induced by intratracheal lipopolysaccharide instillation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy Antigen Receptor for Chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Anticarcinogenic effects of hexaamminecobalt(III) chloride in mice initiated with diethylnitrosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

21 January 2018

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

TNF-α mediates mitochondrial uncoupling and enhances ROS-dependent cell migration via NF-κB activation in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Inhibitor of nuclear factor-κB, SN50, attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Autophagy mediates avian influenza H5N1 pseudotyped particle-induced lung inflammation through NF-κB and p38 MAPK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Mechanism of neutrophil recruitment to the lung after pulmonary contusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Hemorrhagic shock activates lung endothelial reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase via neutrophil NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Additives in intravenous anesthesia modulate pulmonary inflammation in a model of LPS-induced respiratory distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Attenuation of lipopolysaccharide-induced acute lung injury by treatment with IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Renal hypoperfusion and impaired endothelium-dependent vasodilation in an animal model of VILI: the role of the peroxynitrite-PARP pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Models and mechanisms of acute lung injury caused by direct insults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Recombinant human hyaluronidase PH20 does not stimulate an acute inflammatory response and inhibits lipopolysaccharide-induced neutrophil recruitment in the air pouch model of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Requirement for Inducible Nitric Oxide Synthase in Chronic Allergen Exposure-Induced Pulmonary Fibrosis but Not Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Post-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Role of PARP on iNOS pathway during endotoxin-induced acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Poly (ADP-ribose) polymerase as a potential target for the treatment of acute renal injury caused by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Signal transduction in inflammatory processes, current and future therapeutic targets: a mini review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

LPS preconditioning ameliorates intestinal injury in a rat model of hemorrhagic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-2271-4

Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP.

21 January 2018

1 reference

12 December 2020

Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death

1 reference

12 December 2020

Intratracheal aerosolization of endotoxin (LPS) in the rat: a comprehensive animal model to study adult (acute) respiratory distress syndrome.

1 reference

12 December 2020

Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice

1 reference

12 December 2020

Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia

1 reference

12 December 2020

A role of poly (ADP-ribose) polymerase in NF-kappaB transcriptional activation

1 reference

12 December 2020

Sustained lipopolysaccharide-induced lung inflammation in mice is attenuated by functional deficiency of the Fas/Fas ligand system

1 reference

12 December 2020

Pentoxifylline treatment attenuates pulmonary vasomotor dysfunction in acute lung injury

1 reference

12 December 2020

Microsomal lipid peroxidation

1 reference

12 December 2020

Neutrophil Elastase Degrades Cystic Fibrosis Transmembrane Conductance Regulator via Calpains and Disables Channel FunctionIn VitroandIn Vivo

1 reference

12 December 2020

Effect of acute kidney injury on weaning from mechanical ventilation in critically ill patients

1 reference

12 December 2020

The relation between oxidative stress, inflammation, and neopterin in the paraquat-induced lung toxicity.

1 reference

12 December 2020

Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine

1 reference

12 December 2020

Regulation of components of the inflammatory response by 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase and pleiotropic modifier of cellular signal pathways.

1 reference

12 December 2020

Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes

1 reference

12 December 2020

[Prone position for the treatment of acute respiratory distress syndrome: a review of current literature]

1 reference

12 December 2020

10.1007/S11010-014-2271-4

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1015970549

0 references

1 reference